Exhibit 1

AGREEMENT

The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.

Date: February 13, 2026



NAN FUNG GROUP HOLDINGS LIMITED

By:		/s/ Tang Chun Wai Nelson
		Name: Tang Chun Wai Nelson
		Title: Director

NF INVESTMENT HOLDINGS LIMITED

By:		/s/ Tang Chun Wai Nelson
		Name: Tang Chun Wai Nelson
		Title: Director

NAN FUNG LIFE SCIENCES HOLDINGS LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director

NFLS PLATFORM HOLDINGS LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director

NFLS DELTA III LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director

PIVOTAL LIFE SCIENCES HOLDINGS LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director



PIVOTAL PARTNERS LTD

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director

PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD

By:		/s/ Robert Hopfner
		Name: Robert Hopfner
		Title: Director

PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.

By:		PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD
		Its General Partner,

By:		/s/ Robert Hopfner
		Name: Robert Hopfner
		Title: Authorized Signatory

PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.

By:		PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.
		Its General Partner,

By:		PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD
		Its General Partner,

By:		/s/ Robert Hopfner
		Name: Robert Hopfner
		Title: Authorized Signatory


NFLS DELTA LIMITED

By:		/s/ Sun Xintong
		Name: Sun Xintong
		Title: Director


PIVOTAL BIOVENTURE PARTNERS FUND II G.P. LTD

By:		/s/ Peter Tuxen Bisgaard
		Name: Peter Tuxen Bisgaard
		Title: Director


PIVOTAL BIOVENTURE PARTNERS FUND II, L.P.

By:		PIVOTAL BIOVENTURE PARTNERS FUND II G.P. LTD
		Its General Partner,

By:		/s/ Peter Tuxen Bisgaard
		Name: Peter Tuxen Bisgaard
		Title: Director

Evommune, Inc. SCHEDULE 13G